May 15, 2020 / 6:26 AM / 16 days ago

BRIEF-Aspen Pharmacare Says Review & Restructuring Of Europe CIS Business Ongoing

May 15 (Reuters) - Aspen Pharmacare Holdings Ltd:

* VOLUNTARY UPDATE FOR THE 10 MONTHS ENDED 30 APRIL 2020

* STRATEGIC REVIEW AND INTERNAL RESTRUCTURING UNDERTAKEN IN RESPECT OF EUROPE CIS BUSINESS HAS BEEN ONGOING

* STRATEGIC REVIEW AND INTERNAL RESTRUCTURING UNDERTAKEN IN RESPECT OF EUROPE CIS BUSINESS HAS BEEN ONGOING

* CONTINUE TO EXPECT TO FINALISE OUTCOMES OF STRATEGIC REVIEW BY SEPTEMBER 2020

* MANAGEMENT CONTINUE TO EXPECT TO FINALISE OUTCOMES OF STRATEGIC REVIEW, CONCLUDE ON APPROPRIATE COURSE OF ACTION BY SEPT 2020

* MAINTAINS OUTLOOK THAT NORMALISED HEPS FROM CONTINUING OPERATIONS IN FY 2020 TO BE HIGHER VERSUS PCP

* OUTLOOK FOR FY 2020 WILL BE UPDATED IF DEEMED NECESSARY

* HAS REVIEWED AND IS COMFORTABLE WITH ITS LIQUIDITY POSITION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below